Mr. Price's practice has focused on products liability, toxic torts and environmental law, with a particular emphasis on pharmaceutical products and medical devices. He has been involved, both as company counsel and as insurer-appointed counsel, in many large, hotly litigated mass tort controversies.
- Diet drug or "Fen-Phen" litigation, in which the firm was national counsel to the manufacturer of a leading branded phentermine product
- DES litigation as national coordinating counsel for four drug companies, in which he directly participated in the defense of more than 1,000 personal injury lawsuits in the State of New York, and supervised correspondent counsel in an equal number of DES-related lawsuits elsewhere around the United States
- Hemophiliac/Factor VIII AIDS litigation, in which he represented one of the blood fractionator defendants in New York State
- National defense of the world's largest generic drug manufacturer in more than 5,000 lawsuits relating to the drug metoclopramide (generic Reglan®)
- National defense of the world's largest generic drug manufacturer in almost 1,000 lawsuits relating to the drug alendronate (generic Fosamax®)
- Litigation involving Prozac®, PPA, acetaminophen (alcohol liver toxicity syndrome), doxycycline hyclate, sulfamethoxazole with trimethoprim, chloroquine phosphate, amoxicillin, Copaxone®, diflunisal, cephalexin, ciprofloxacin, gabapentin, gemfibrozil, psyllium powder, paroxetine, bupropion, phenytoin, trazodone, minocycline, propofol and methazolamide.
- Cases relating to allegedly defective passive motion exercise devices and dental bone drills
- Defense of a major automotive and heavy machinery manufacturing company in a lawsuit in which the City of New York sought damages for defectively designed and manufactured subway car carriages.
Before joining Goodwin, Mr. Price was a partner at Schneck Weltman & Hashmall LLP in New York City.